IC
GCTK icon

Ikarian Capital’s GlucoTrack GCTK Stock Holding History

Ikarian Capital’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Hold
3,055
– – ﹤0.01% 153
2026
Q1 		$29.8K Hold
3,055
– – ﹤0.01% 158
2025
Q4 		$177K Buy
+3,055
New +$272K 0.01% 156

Other funds holding GCTK

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GIPW
Granite Islands Private Wealth Guilford, Connecticut $135M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Ikarian Capital's GCTK Position: Q2 2026 in Review

Ikarian Capital held its GlucoTrack (GCTK) position steady in Q2 2026 at 3,055 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #153.

Ikarian Capital first reported a position in GCTK in Q4 2025 and has held it in 3 quarters since. The position peaked at $177K in Q4 2025. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Ikarian Capital held 3,055 shares of GlucoTrack worth $14.6K as of Q2 2026.
  • Ikarian Capital left its GlucoTrack share count unchanged in Q2 2026.
  • GlucoTrack made up ﹤0.01% of Ikarian Capital's portfolio in Q2 2026, its #153 holding.
  • Ikarian Capital first reported a position in GlucoTrack in Q4 2025 and has held it in 3 quarters since.
  • Ikarian Capital's GlucoTrack position peaked at $177K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.